CAN
BPMC

Cetera Advisor Networks’s Blueprint Medicines BPMC Stock Holding History

Cetera Advisor Networks’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$625K Buy
6,585
+1,512
+30% +$130K ﹤0.01% 1781
2023
Q4 		$468K Buy
+5,073
New +$329K ﹤0.01% 1926

Other funds holding BPMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Advisor Networks's BPMC Position: Q1 2024 in Review

Cetera Advisor Networks increased its Blueprint Medicines (BPMC) stake by 30% in Q1 2024, buying an estimated $130K and bringing the position to 6,585 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Cetera Advisor Networks first reported a position in BPMC in Q4 2023 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold BPMC as of Q1 2024.

  • Cetera Advisor Networks held 6,585 shares of Blueprint Medicines worth $625K as of Q1 2024.
  • Cetera Advisor Networks bought 1,512 Blueprint Medicines shares in Q1 2024, an estimated $130K.
  • Blueprint Medicines made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1781 holding.
  • Cetera Advisor Networks first reported a position in Blueprint Medicines in Q4 2023 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.